Novel Innate Receptor for the Fungal PAMP chitin
Novel Innate Receptor for the Fungal PAMP chitin
批准号:
8839039
负责人:
LIWU LI
金额:
$23.37万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-18 至 2017-04-30
关键词:
AcetylglucosamineAgeAlkaliesAllergensAllergicAllergic DiseaseAllergic rhinitisAlternariaAnimal ModelAspergillus fumigatusAsthmaAutomobile DrivingBindingBiochemicalBreathingCD4 Positive T LymphocytesCalorimetryCarbohydratesCell WallCell membraneCellsCessation of lifeChildChildhoodChitinChronicClinicalCollaborationsComplexCountryDataDendritic CellsDeveloped CountriesDevelopmentDiseaseEmployee StrikesEnvironmental Risk FactorEosinophiliaEpithelial CellsEquilibriumEventExhibitsExposure toExtrinsic asthmaFungal AntigensGenesGlucansGoalsHealthcare SystemsHumanHypersensitivityIRAK1 geneIgEImmuneImmune responseImmune systemImmunityIn VitroIndividualInflammationInflammatoryInflammatory ResponseInvestigationKineticsKnowledgeLeadLigandsLinkLungMucous body substanceMusNatural ImmunityNatureObstructionParasitesPathogenesisPathway interactionsPatientsPeptidoglycanPhasePhenotypePhosphotransferasesPlayPolymersPopulationPrevalencePreventionPrevention strategyProcessProductionProteinsPublic HealthRecombinantsRecurrenceReproduction sporesResearchRhinitisRoleSerumSignal TransductionSiteSmall Interfering RNASpecificityTestingTitrationsTranslatingUnited StatesUnited States National Institutes of HealthVariantWorkadaptive immunityairway hyperresponsivenessairway inflammationairway remodelingallergic airway diseaseallergic airway inflammationallergic responseclinical practicecytokinedectin 1designeffective therapyexperiencefallsfungusgalactomannanhuman IRAK1 proteinin vivoinsightmouse modelmutantnovelnovel therapeutic interventionpathogenpressurepublic health relevancereceptorresponsescreening
中文摘要
描述(申请人提供):过敏性哮喘的炎性呼吸道反应可能是免疫细胞对环境因素(如空气中的真菌)调节失调的结果。该项目的长期目标是更好地了解Th2型(过敏性)呼吸道炎症的病理生理机制。长期接触这种真菌,交链孢霉,一直与过敏性呼吸道疾病的发展和恶化有关,如鼻炎、特应性哮喘和CRS。在鼻腔接触交链孢子、抗原和真菌细胞壁聚合物如甲壳素后,幼小鼠表现出明显的嗜酸性呼吸道炎症,Th2反应增强,呼吸道高反应性。尽管交链孢霉在过敏性呼吸道疾病的发生、发病和加重中的临床重要性已经得到了很好的证明,但对单个真菌产品/成分在这些病理状态中的作用知之甚少。真菌细胞壁聚合物甲壳素的重要性已在一定程度上被探索在炎症的背景下,并已被证明推动免疫反应有利于过敏性疾病的发展。我们发现了一种在肺上皮细胞中表达的甲壳素的新的候选受体。在这个探索性的项目中,我们将进一步了解几丁质如何与该受体结合,并开始利用肺上皮细胞和小鼠模型阐明该受体候选在先天免疫和变态反应性炎症反应中的作用。该项目的实施将有助于更好地了解持续性和复发性呼吸道炎症的机制,并可能导致开发更具体、有效的治疗和预防策略。
英文摘要
DESCRIPTION (provided by applicant): The inflammatory airway response in allergic asthma may be the result of immune cells that are dysregulated towards environmental factors such as airborne fungi. The long-term goal of this project is to better understand the pathophysiological mechanisms of Th2-type (allergic) airway inflammation. Exposure to the fungus, Alternaria, has long been implicated in the development and exacerbation of allergic airway disorders such as rhinitis, atopic asthma, and CRS. After intranasal exposure to Alternaria spores, antigens, and fungal cell wall polymers such as chitin, naive mice exhibit marked eosinophilic airway inflammation, enhanced Th2 responses, and airway hyperreactivity. Despite the well-documented clinical importance of Alternaria in the development, onset, and exacerbation of allergic airway diseases, little knowledge exists about the role of individual fungal products/components in theses pathological states. The importance of the fungal cell wall polymer chitin has been explored to some extent in the context of inflammation and has been shown to drive immune responses favoring the development of allergic disease. We have discovered a novel receptor candidate for chitin expressed in lung epithelial cells. In this exploratory project we will further our understanding of how chitin binds to this receptor and begin to elucidate the role of this receptor candidate in the context of innate immunity and allergic inflammatory responses using lung epithelial cells and mouse models. Execution of this project will lead to a better understanding of the mechanisms of persistent and recurrent airway inflammation and may lead to the development of more specific, effective therapies and prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of innate immune exhaustion during sepsis
-
批准号:10680874
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2023
-
负责人:LIWU LI
-
依托单位:
Novel mechanisms for the generation of resolving monocytes
-
批准号:10586050
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2022
-
负责人:LIWU LI
-
依托单位:
Altered innate leukocyte programming dynamics in sepsis
-
批准号:10292455
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2017
-
负责人:LIWU LI
-
依托单位:
Altered innate leukocyte programming dynamics in sepsis
-
批准号:10058758
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2017
-
负责人:LIWU LI
-
依托单位:
Altered innate leukocyte programming dynamics in sepsis
-
批准号:9469986
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2017
-
负责人:LIWU LI
-
依托单位:
Innate priming in sepsis exacerbation
-
批准号:8882579
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2014
-
负责人:LIWU LI
-
依托单位:
Annual meeting of SLB and IEIIS
-
批准号:8783857
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2014
-
负责人:LIWU LI
-
依托单位:
Innate Cell Plasticity Conference-Society of Leukocyte Biology
-
批准号:8592450
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2013
-
负责人:LIWU LI
-
依托单位:
Innate Modulation of Macrophage Homeostasis
-
批准号:8852690
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
Innate Modulation of Macrophage Homeostasis
-
批准号:9081637
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
Modulation of innate immune cellular homeostasis and inflammation resolution
-
批准号:9914112
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
Innate Modulation of Macrophage Homeostasis
-
批准号:8390984
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
Innate Modulation of Macrophage Homeostasis
-
批准号:8686071
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
Innate Modulation of Macrophage Homeostasis
-
批准号:8509783
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2012
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:8077726
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2010
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:7127456
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2005
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:7185092
-
项目类别:
-
资助金额:$35.41万
-
财政年份:2005
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:7578978
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2005
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:7368061
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2005
-
负责人:LIWU LI
-
依托单位:
The novel role and regulation of IRAK in innate immunity
-
批准号:6902779
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2005
-
负责人:LIWU LI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: